Waltz Health

?? TOMORROW @ #ViVEvent Waltz Co-Founder and SVP of Product, Jonathon Thierer, is taking the stage with an incredible group of panelists to discuss new approaches to patient care in the evolving world of retail health. If you're in Nashville for #ViVE2025, stop by the Rock-N-Roll stage to hear from Jon, Rina Shah (Walgreens), Laura Jensen (Amazon Pharmacy), Patrick Carroll (hims & hers), and moderator Pooja Babbrah (NCPDP (National Council for Prescription Drug Programs, Inc.)).

Heading to #ViVEvent this month? Don't miss our Co-Founder and SVP of Product, Jonathon Thierer, on an exciting panel digging into the challenges and opportunities shaping the next era of retail pharmacy! #ViVE2025

The prescription medication landscape in 2024 was marked by rising costs, drug shortages, and barriers to access—but there’s a path forward. Explore how innovative solutions like AI-driven insights and transparent pricing models can reshape pharmaceutical care for the better in 2025. Read our latest blog from Waltz Health President,?Jeff Park, to see what’s ahead: https://lnkd.in/gWCjdWrH

Great feature from Fierce Healthcare. We're excited to see Waltz Connect transform specialty pharmacy management with partners like CerpassRx!

JUST IN: CerpassRx is rolling out its new AI-enabled engine, powered by Waltz Connect, to help health plans and employers drive specialty medication savings. By intelligently routing prescriptions to the most cost-effective, clinically appropriate pharmacies, this solution prioritizes affordability and a seamless experience for patients and payers alike. #pharmacybenefits #AIsolutions #specialtypharmacy

The rise of GLP-1 medications has transformed obesity treatment but the rising demand has exposed challenges in cost, access, and adherence. This evolving landscape presents several opportunities for healthcare and pharmacy leaders to enhance the impact of GLP-1 medications in the fight against obesity. Read more from Waltz Senior Vice President, Brian Laird, on how we're working to solve these problems for payers and patients: https://lnkd.in/gxMasCuX #GLP1 #obesitytreatment #drugaccess #affordability #adherence

It's an exciting day at Waltz as we announced a first-of-its-kind partnership with Noom! This collaboration focuses on supporting employers in delivering affordable and accessible GLP-1 medications for their employees. Read the full announcement here: https://lnkd.in/geMZJPWB

We are thrilled to announce our partnership with Noom to provide a comprehensive and more affordable weight loss program for employers! This collaboration combines Noom's personalized, behavior science-driven program with our Waltz Connect platform to offer employees access to personalized, sustainable weight loss support. https://lnkd.in/gdctSpBt

?? Reliance Rx Specialty Pharmacy Joins Waltz Connect to Lower Specialty Medication Costs We’re proud to announce our partnership with leading specialty pharmacy, Reliance Rx! As an in-network partner in the Waltz Connect marketplace, Reliance Rx brings its high-touch, high-quality services to our network, further enhancing our ability to deliver cost-effective, patient-centered care. Together, we’re committed to transforming specialty medication management and driving down costs for patients. Learn more about the partnership: https://lnkd.in/giya85tv

We’re thrilled to announce the launch of Waltz Connect, our latest technology-driven solution designed to lower costs of specialty medications. This new end-to-end solution includes proprietary technology, patient engagement support, and a first-of-its-kind dynamic marketplace with a network of high-quality specialty pharmacies. Learn more about how Waltz Connect can transform specialty medication coverage: https://lnkd.in/g5yjcRV8